DE69526934D1 - Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere - Google Patents
Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymereInfo
- Publication number
- DE69526934D1 DE69526934D1 DE69526934T DE69526934T DE69526934D1 DE 69526934 D1 DE69526934 D1 DE 69526934D1 DE 69526934 T DE69526934 T DE 69526934T DE 69526934 T DE69526934 T DE 69526934T DE 69526934 D1 DE69526934 D1 DE 69526934D1
- Authority
- DE
- Germany
- Prior art keywords
- nitric oxide
- releasing
- delivery means
- medicines
- restenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/214,372 US5650447A (en) | 1992-08-24 | 1994-03-17 | Nitric oxide-releasing polymers to treat restenosis and related disorders |
PCT/US1995/003040 WO1995024908A1 (en) | 1994-03-17 | 1995-03-09 | Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69526934D1 true DE69526934D1 (de) | 2002-07-11 |
DE69526934T2 DE69526934T2 (de) | 2003-01-02 |
Family
ID=22798839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69526934T Expired - Fee Related DE69526934T2 (de) | 1994-03-17 | 1995-03-09 | Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere |
Country Status (11)
Country | Link |
---|---|
US (1) | US5650447A (de) |
EP (1) | EP0752866B1 (de) |
JP (1) | JPH10502905A (de) |
AT (1) | ATE218352T1 (de) |
AU (1) | AU698525B2 (de) |
CA (1) | CA2185457C (de) |
DE (1) | DE69526934T2 (de) |
DK (1) | DK0752866T3 (de) |
ES (1) | ES2177637T3 (de) |
PT (1) | PT752866E (de) |
WO (1) | WO1995024908A1 (de) |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5632981A (en) * | 1992-08-24 | 1997-05-27 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US6255277B1 (en) | 1993-09-17 | 2001-07-03 | Brigham And Women's Hospital | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
GB9423868D0 (en) * | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
ES2244966T3 (es) * | 1994-12-12 | 2005-12-16 | Omeros Corporation | Solucion de irrigacion y su utilizacion para inhibir perioperatoriamente el dolor, la inflamacion y el espasmo en una herida. |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US20050152950A1 (en) * | 1995-11-13 | 2005-07-14 | Saffran Bruce N. | Method and apparatus for macromolecular delivery using a coated membrane |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6232434B1 (en) | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
AU3986097A (en) * | 1996-08-27 | 1998-03-19 | University Of Akron, The | Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use |
US6372796B1 (en) * | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6221425B1 (en) | 1998-01-30 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Lubricious hydrophilic coating for an intracorporeal medical device |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US5962520A (en) * | 1998-04-02 | 1999-10-05 | The University Of Akron | Hydrolytically unstable, biocompatible polymer |
US6207855B1 (en) | 1998-06-23 | 2001-03-27 | Duke University Medical Center | Stable no-delivering compounds |
US20040043068A1 (en) * | 1998-09-29 | 2004-03-04 | Eugene Tedeschi | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
US6645167B1 (en) * | 1999-05-21 | 2003-11-11 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an embolizing composition |
WO2000071064A1 (en) * | 1999-05-21 | 2000-11-30 | Micro Therapeutics, Inc. | Methods for delivering in vivo uniform dispersed embolic compositions of high viscosity |
US7018365B2 (en) | 1999-05-21 | 2006-03-28 | Micro Therapeutics, Inc. | Threaded syringe with quick stop |
WO2001010344A1 (en) * | 1999-08-04 | 2001-02-15 | C.R. Bard, Inc. | Nitric oxide releasing medical devices |
US6569082B1 (en) | 1999-08-10 | 2003-05-27 | Origin Medsystems, Inc. | Apparatus and methods for cardiac restraint |
US7597698B2 (en) * | 1999-08-10 | 2009-10-06 | Maquet Cardiovascular Llc | Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablation |
US7288096B2 (en) | 2003-01-17 | 2007-10-30 | Origin Medsystems, Inc. | Apparatus for placement of cardiac defibrillator and pacer |
US20030187461A1 (en) * | 1999-08-10 | 2003-10-02 | Chin Albert K. | Releasable guide and method for endoscopic cardiac lead placement |
US20040102804A1 (en) * | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US7526342B2 (en) * | 1999-08-10 | 2009-04-28 | Maquet Cardiovascular Llc | Apparatus for endoscopic cardiac mapping and lead placement |
US7398781B1 (en) | 1999-08-10 | 2008-07-15 | Maquet Cardiovascular, Llc | Method for subxiphoid endoscopic access |
US20060287574A1 (en) * | 1999-08-25 | 2006-12-21 | Chin Albert K | Longitudinal dilator |
US6660260B1 (en) * | 1999-09-21 | 2003-12-09 | Mayo Foundation For Medical Education And Research | Bioprosthetic heart valves |
ATE460951T1 (de) | 2000-01-25 | 2010-04-15 | Edwards Lifesciences Corp | Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie |
US6270779B1 (en) | 2000-05-10 | 2001-08-07 | United States Of America | Nitric oxide-releasing metallic medical devices |
CA2414941C (en) | 2000-08-11 | 2010-12-14 | David R. Whitlock | Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
US6797743B2 (en) * | 2000-09-27 | 2004-09-28 | Michigan Biotechnology Institute | Antimicrobial polymer |
US20050043506A1 (en) * | 2000-09-27 | 2005-02-24 | Michigan Biotechnology Institute | Polyamide materials based on unsaturated carboxylic acids and amines |
WO2002030487A2 (en) | 2000-10-11 | 2002-04-18 | Micro Thereapeutics, Inc. | Methods for treating aneurysms |
PT1328213E (pt) | 2000-10-16 | 2005-10-31 | Conor Medsystems Inc | Dispositivo medico expansivel para a administracao de um agente benefico |
US7049308B2 (en) * | 2000-10-26 | 2006-05-23 | Duke University | C-nitroso compounds and use thereof |
US6565601B2 (en) | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
CA2433861A1 (en) * | 2000-12-27 | 2002-07-04 | Genzyme Corporation | Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
US20040073294A1 (en) | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
WO2002087508A2 (en) | 2001-05-02 | 2002-11-07 | Nitromed, Inc. | Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
WO2003026717A1 (en) * | 2001-09-26 | 2003-04-03 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Nitric oxide-releasing coated medical devices and method of preparing same |
US6703046B2 (en) * | 2001-10-04 | 2004-03-09 | Medtronic Ave Inc. | Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
JP2005515218A (ja) * | 2002-01-11 | 2005-05-26 | ホイットロック,デービッド,アール. | アンモニア酸化細菌を含む組成物およびその使用方法 |
US6939554B2 (en) * | 2002-02-05 | 2005-09-06 | Michigan Biotechnology Institute | Antimicrobial polymer |
WO2003080730A1 (en) | 2002-03-20 | 2003-10-02 | Michigan Biotechnology Institute | Conductive polymer-based material |
US8404665B2 (en) * | 2002-03-21 | 2013-03-26 | University Of Utah Research Foundation | In vivo use of glutathione S-transferase activated nitric oxide donors |
EP1507526A2 (de) * | 2002-05-07 | 2005-02-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Polydiazeniumdiolierte cyclische polyamine mit polyphasischer stickoxid-freisetzung und verwandte verbindungen, diese enthaltende zusammensetzungen und anwendungsverfahren dafür |
WO2003095623A2 (en) * | 2002-05-10 | 2003-11-20 | The Trustees Of Columbia University In The City Of New York | Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof |
JP2005534485A (ja) | 2002-08-02 | 2005-11-17 | アメリカ合衆国 | 架橋した一酸化窒素−放出ポリアミン被覆基質、それを含む組成物及びその製造方法 |
US6951902B2 (en) * | 2002-08-16 | 2005-10-04 | Michigan Biotechnology Institute | Two dimensional polymer that generates nitric oxide |
EP2289571B1 (de) | 2003-03-28 | 2016-08-03 | Innovational Holdings, LLC | Implantierbare medizinische vorrichtung mit kontinuerlichem gradienten einer therapeutischen substanz |
DK1624953T3 (en) * | 2003-04-23 | 2019-04-01 | Univ Akron | Sequestered reactive materials |
PL1648826T3 (pl) * | 2003-07-03 | 2018-02-28 | The University Court Of The University Of St. Andrews | Zeolity do dostarczania tlenku azotu |
CA2536173A1 (en) * | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
AU2004270161A1 (en) * | 2003-08-28 | 2005-03-17 | Nicox S.A. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
US7785653B2 (en) | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US7379190B2 (en) * | 2004-01-05 | 2008-05-27 | Zygo Corporation | Stage alignment in lithography tools |
JP2007526911A (ja) * | 2004-01-22 | 2007-09-20 | ザ ユニバーシティ オブ アクロン | 医療装置および治療のためのポリマーno供与体プレドラッグナノファイバコーティング |
WO2005070006A2 (en) * | 2004-01-22 | 2005-08-04 | Nitromed, Inc. | Nitrosated and/or nitrosylated compounds, compositions and methods of use |
US20050165452A1 (en) * | 2004-01-28 | 2005-07-28 | Medtronic, Inc. | Antithrombogenic medical device |
US7829553B2 (en) * | 2004-02-09 | 2010-11-09 | Amulet Pharmaceuticals, Inc. | Nitric oxide-releasing polymers |
US20070191377A1 (en) * | 2004-03-31 | 2007-08-16 | Nitromed, Inc. | Methods for treating blood disorders with nitric oxide donor compounds |
US20060039950A1 (en) * | 2004-08-23 | 2006-02-23 | Zhengrong Zhou | Multi-functional biocompatible coatings for intravascular devices |
EP1794195B1 (de) | 2004-09-27 | 2014-12-17 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | Stickoxidabgebende diazeniumdiolisierte acrylnitrilbasierte polymere und zusammensetzungen, medizinische vorrichtungen und verwendungen damit |
WO2006041855A2 (en) | 2004-10-04 | 2006-04-20 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
EP1814535A4 (de) * | 2004-11-08 | 2008-06-04 | Nitromed Inc | Nitrosierte und nitrosylierte verbindungen, zusammensetzungen und verfahren zur behandlung von augenkrankheiten |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
EP1690532A1 (de) * | 2005-02-11 | 2006-08-16 | NOLabs AB | Vorrichtung zur Behandlung vom Magen und ihr Verfahren zur Herstellung |
JP5175107B2 (ja) * | 2005-02-11 | 2013-04-03 | ノーラブズ エービー | 酸化窒素による神経障害の治療デバイス、方法および使用 |
WO2006084914A2 (en) * | 2005-02-11 | 2006-08-17 | Nolabs Ab | Device for gastric treatment and manufacturing process for the same |
WO2006093864A1 (en) * | 2005-02-28 | 2006-09-08 | Nitromed, Inc. | Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use |
JP2008533031A (ja) * | 2005-03-09 | 2008-08-21 | ニトロメッド インコーポレーティッド | アンギオテンシンiiアンタゴニストの有機酸化窒素増強塩、組成物および使用法 |
JP2008535858A (ja) * | 2005-04-07 | 2008-09-04 | ニトロメッド インコーポレーティッド | 心不全における遺伝リスク、すなわちnos3の遺伝子変異の影響の評価方法 |
US20090048219A1 (en) * | 2005-05-23 | 2009-02-19 | Nitromed Inc. | Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
EP2669269B1 (de) | 2005-05-27 | 2019-05-22 | The University of North Carolina At Chapel Hill | Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen |
WO2007005758A2 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Methods , compositions and devices for promoting angiogenesis |
CA2613108A1 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Nitric oxide coatings for medical devices |
CA2613106A1 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Analyte sensors and compositions for use therein |
US20090018091A1 (en) * | 2005-08-02 | 2009-01-15 | Nitromed, Inc. | Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
US8021679B2 (en) | 2005-08-25 | 2011-09-20 | Medtronic Vascular, Inc | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
US20070053952A1 (en) * | 2005-09-07 | 2007-03-08 | Medtronic Vascular, Inc. | Nitric oxide-releasing polymers derived from modified polymers |
EP1945030A4 (de) * | 2005-10-04 | 2009-10-21 | Nitromed Inc | Genetische risikobeurteilung bei herzversagen: einfluss der genetischen variation auf den gly389arg-polymorphismus des beta 1 adrenergen rezeptors |
AU2006309212B2 (en) * | 2005-10-31 | 2011-09-15 | Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services | Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
WO2007059311A2 (en) * | 2005-11-16 | 2007-05-24 | Nitromed, Inc. | Furoxan compounds, compositions and methods of use |
JP2009518069A (ja) * | 2005-12-02 | 2009-05-07 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | 組成物、コーティング及びデバイス、並びにそれらの製造方法及び使用方法 |
AU2006322035A1 (en) * | 2005-12-06 | 2007-06-14 | Amulet Pharmaceuticals, Inc. | Nitric oxide-releasing polymers |
EP1968584A2 (de) * | 2005-12-20 | 2008-09-17 | Nitromed, Inc. | Stickoxid-verstärkende glutaminsäure-verbindungen, zusammensetzungen und anwendungsverfahren |
AU2007243765A1 (en) * | 2006-03-29 | 2007-11-08 | Nicox S.A. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
US8241619B2 (en) * | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
US8273828B2 (en) | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
US20100316622A1 (en) * | 2007-11-02 | 2010-12-16 | University Of Miami | Diagnosis and treatment of cardiac disorders |
WO2009064861A2 (en) * | 2007-11-13 | 2009-05-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitric oxide-releasing diazeniumdiolated polymers, compositions, medical devices, and uses thereof |
US20090170933A1 (en) * | 2007-12-26 | 2009-07-02 | Cook Incorporated | Method for removing a medical device from a spasmodic constriction in a bodily passageway |
US20090222088A1 (en) * | 2008-02-29 | 2009-09-03 | Medtronic Vascular, Inc. | Secondary Amine Containing Nitric Oxide Releasing Polymer Composition |
WO2009114368A2 (en) | 2008-03-07 | 2009-09-17 | University Of Utah Research Foundation | Activated nitric oxide donors and methods of making and using thereof |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
WO2009123713A1 (en) | 2008-04-01 | 2009-10-08 | Cornell University | Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
AU2010249558A1 (en) | 2009-05-20 | 2011-12-08 | Arsenal Medical, Inc. | Medical implant |
US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
TWI626057B (zh) | 2009-06-09 | 2018-06-11 | 普龍製藥有限責任公司 | 血紅素組成物 |
EP2467127B1 (de) | 2009-08-21 | 2023-08-02 | Novan, Inc. | Topische gele |
WO2011022680A2 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
US8372133B2 (en) * | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
US20110301299A1 (en) | 2010-06-08 | 2011-12-08 | Medtronic Vascular, Inc. | Medical Devices and Polymers Therefor Having PTFE Surfaces Modified With Nitric Oxide-Releasing Polymers |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
ES2695173T3 (es) | 2011-02-28 | 2019-01-02 | Novan Inc | Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas |
EP2707103A2 (de) | 2011-05-09 | 2014-03-19 | Topical Therapeutic Agent (TTA) Ltd. | Stickoxidsequestrierung von topischen formulierungen |
CN111057660B (zh) | 2014-04-15 | 2023-10-31 | Ao生物医学有限责任公司 | 氨氧化型亚硝化单胞菌菌株d23 |
US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
EP3180366B1 (de) * | 2014-08-14 | 2018-09-26 | Rohm and Haas Company | Polymer mit freisetzbarem gas |
DK3253485T3 (da) | 2015-02-03 | 2022-03-21 | Univ Court Univ St Andrews | No-holdige sammensætninger |
WO2018067838A1 (en) | 2016-10-07 | 2018-04-12 | The University Of North Carolina At Chapel Hill | S-nitrosothiol-mediated hyperbranched polyesters |
EP3565848A4 (de) | 2017-01-03 | 2020-09-02 | The University of North Carolina at Chapel Hill | Stickoxidfreisetzende alginate als biologisch abbaubare antibakterielle gerüste und zugehörige verfahren |
CN110461338A (zh) | 2017-03-28 | 2019-11-15 | 北卡罗来纳大学查佩尔希尔分校 | 作为可生物降解抗菌支架的释放一氧化氮的聚氨基糖苷类和其制备方法 |
WO2019173539A1 (en) | 2018-03-06 | 2019-09-12 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto |
JP2022516461A (ja) | 2018-12-28 | 2022-02-28 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法 |
WO2023081681A1 (en) * | 2021-11-03 | 2023-05-11 | Baxter International Inc. | Nitric oxide donors for use in surgical recovery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA998495A (en) * | 1971-04-15 | 1976-10-12 | Snamprogetti S.P.A. | Modified polyisoprene and process for the preparation thereof |
US4954526A (en) * | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
US5208233A (en) * | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5212204A (en) * | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
US5155137A (en) * | 1990-09-20 | 1992-10-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complexes of nitric oxide with polyamines |
US5185376A (en) * | 1991-09-24 | 1993-02-09 | The United States Of America As Represented By The Department Of Health And Human Services | Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof |
US5219710A (en) * | 1991-11-25 | 1993-06-15 | Allied-Signal Inc. | Polymeric nitrones having a styrene-derived backbone chain |
-
1994
- 1994-03-17 US US08/214,372 patent/US5650447A/en not_active Expired - Fee Related
-
1995
- 1995-03-09 AU AU19889/95A patent/AU698525B2/en not_active Ceased
- 1995-03-09 AT AT95912871T patent/ATE218352T1/de not_active IP Right Cessation
- 1995-03-09 PT PT95912871T patent/PT752866E/pt unknown
- 1995-03-09 EP EP95912871A patent/EP0752866B1/de not_active Expired - Lifetime
- 1995-03-09 ES ES95912871T patent/ES2177637T3/es not_active Expired - Lifetime
- 1995-03-09 JP JP7524103A patent/JPH10502905A/ja active Pending
- 1995-03-09 DE DE69526934T patent/DE69526934T2/de not_active Expired - Fee Related
- 1995-03-09 WO PCT/US1995/003040 patent/WO1995024908A1/en active IP Right Grant
- 1995-03-09 CA CA002185457A patent/CA2185457C/en not_active Expired - Fee Related
- 1995-03-09 DK DK95912871T patent/DK0752866T3/da active
Also Published As
Publication number | Publication date |
---|---|
AU698525B2 (en) | 1998-10-29 |
DE69526934T2 (de) | 2003-01-02 |
US5650447A (en) | 1997-07-22 |
EP0752866B1 (de) | 2002-06-05 |
WO1995024908A1 (en) | 1995-09-21 |
PT752866E (pt) | 2002-11-29 |
CA2185457A1 (en) | 1995-09-21 |
ES2177637T3 (es) | 2002-12-16 |
JPH10502905A (ja) | 1998-03-17 |
ATE218352T1 (de) | 2002-06-15 |
DK0752866T3 (da) | 2002-09-16 |
EP0752866A1 (de) | 1997-01-15 |
AU1988995A (en) | 1995-10-03 |
CA2185457C (en) | 2004-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69526934D1 (de) | Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere | |
ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
BR9814389A (pt) | Forma de dosagem farmacêutica revestida entérica, processo para a preparação da mesma, uso desta, pelota ou tablete encamado para a mesma, e, processos para melhorar a inibição da secreção de ácido gástrico, e para melhorar o efeito terapêutico no tratamento de distúrbios gastrointestinais associados com secreção de ácido em excesso | |
DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
ATE311867T1 (de) | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
DE69805202T2 (de) | Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs | |
DE69906671D1 (de) | Substituierte 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanone, deren Verwendung zur Behandlung von Erkrankungen des zentralen und periphären Nervensystems und diese enthaltende pharmazeutische Zusammensetzungen | |
ATE171869T1 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
DE69424777T2 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
ATE232390T1 (de) | Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs | |
ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
ATE255411T1 (de) | Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose | |
NZ594154A (en) | Transdermal administration of buprenorphine for preoperative treatment of post operative pain | |
DE69623316T2 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
ATE247965T1 (de) | Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung | |
BR9808063A (pt) | Métodos para tratamento de distúrbios vasculares. | |
HUP9801628A2 (hu) | Artritisz elleni gyógyászati készítmények | |
DE60006284D1 (de) | Arzneimittel zur behandlung konvulsivischer zustände | |
DE69729120D1 (de) | Arzneipräparat und verfahren zur behandlung und vorbeugung von fybromyalgie und des chronischen ermüdungssyndrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |